NLEM Exposure Of Top Indian Drugmakers

As per Sept. FY22 sales data as per 2015-NLEM list*

(Please use a modern browser to see the interactive version of this visualization)

* Sanofi and JB Pharma data updated as per inclusions in revised 2022-NLEM list. It is based on estimated exposure as per IIFL Securities' reports dated Feb 27 and Feb 10 respectively. # GSK Pharma exposure higher than stated due to two new products in revised 2022 list

Source: AIOCD, IIFL Securities